DCGI expert panel holds meet on recommendations to use Corbevax, Covaxin vaccines for 5-12 age group
India is currently administering two COVID-19 vaccines for children above 12

New Delhi: The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged 5-12, said sources on Thursday.
The Corbevax is currently being administered to children in the age group of 12-14.
COVID-19 vaccinations for minors in India was started from 3 January onwards with those in the 15-18 age group for Bharat Biotech's Covaxin.
The drive later expanded on 16 March to include children aged above 12 for Corbevax.
Overall India is currently administering two COVID-19 vaccines for children above 12.
Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge
Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs
Spices, health and the Indian plate: Why chilli can be good for you—but moderation is still key
Organ donation: 5 myths you need to stop believing, according to a transplant specialist
Fish over meat: Why a pescatarian diet may help people with obesity live longer
